Collection of Blood and Bone Marrow from Allogeneic Hematopoietic Cell Transplant Recipients and their Related Donors
||Main Campus|| || ||Aplastic Anemia, Bone Cancer, Bone Marrow Failure, Leukemia, Acute Lymphoblastic (ALL) , Leukemia, Acute Myeloid (AML), Leukemia, Chronic Lymphocytic (CLL), Leukemia, Chronic Myeloid (CML), Lymphoma, Lymphoma, Hodgkin, Lymphoma, Non - Hodgkin, Multiple Myeloma, Myelodysplastic Syndrome (MDS)
A Phase 3 randomized trial of Blinatumomab for newly diagnosed BCR-ABL negative B lineage acute lymphoblastic leukemia in adults
||Main Campus|| ||Phase 3||Leukemia, Acute Lymphoblastic (ALL)
S1312 testing the addition of Inotuzumab Ozogamicin to usual chemotherapy in relapsed and refractory acute leukemia
||Main Campus|| ||Phase 1||Leukemia, Acute Lymphoblastic (ALL) , Leukemia, Acute Myeloid (AML)
A Phase II Study of Blinatumomab (NSC-765986) and POMP (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) for Patients greater than or equal to 65 Years of Age with Newly Diagnosed Philadelphia-Chromosome Negative (Ph-) Acute Lymphoblastic Leukemia (ALL) and of Dasatinib (NSC-732517), Prednisone and Blinatumomab for Patients greater than or equal 65 Years of Age with Newly Diagnosed Philadelphia-Chromosome Positive (Ph+) ALL.
||Main Campus|| || ||Leukemia, Acute Lymphoblastic (ALL)